These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1365420)

  • 21. In vivo autoradiography of [3H]SCH 39166 in rat brain: selective displacement by D1/D5 antagonists.
    Duffy RA; Hunt MA; Wamsley JK; McQuade RD
    J Chem Neuroanat; 2000 May; 19(1):41-6. PubMed ID: 10882836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists.
    Giorgi O; Biggio G
    Brain Res; 1990 Nov; 533(1):53-9. PubMed ID: 1982234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential modification of striatal D1 dopamine receptors and effector moieties by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo and in vitro.
    Hess EJ; Battaglia G; Norman AB; Creese I
    Mol Pharmacol; 1987 Jan; 31(1):50-7. PubMed ID: 3100940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perinatal asphyxia induces long-term changes in dopamine D1, D2, and D3 receptor binding in the rat brain.
    Chen Y; Hillefors-Berglund M; Herrera-Marschitz M; Bjelke B; Gross J; Andersson K; von Euler G
    Exp Neurol; 1997 Jul; 146(1):74-80. PubMed ID: 9225740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine receptor blockade increases dopamine D2 receptor and glutamic acid decarboxylase mRNAs in mouse substantia nigra.
    Qin ZH; Weiss B
    Eur J Pharmacol; 1994 Sep; 269(1):25-33. PubMed ID: 7828655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopaminergic behaviors and signal transduction mediated through adenylate cyclase and phospholipase C pathways.
    Undie AS; Berki AC; Beardsley K
    Neuropharmacology; 2000; 39(1):75-87. PubMed ID: 10665821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unilateral inactivation of dopamine receptors after intrastriatal injection of N-ethoxy-carbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ): a novel rotational model to investigate dopamine receptor interactions.
    Giorgi O; Biggio G
    Pharmacol Biochem Behav; 1990 Apr; 35(4):877-84. PubMed ID: 1971721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic treatment with (-)-stepholidine alters density and turnover of D1 and D2 receptors in striatum.
    Zou LL; Cai ST; Jin GZ
    Zhongguo Yao Li Xue Bao; 1996 Nov; 17(6):485-9. PubMed ID: 9863137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Localization of dopamine receptor subtypes in corpus striatum and nucleus accumbens septi of rat brain: comparison of D1-, D2-, and D4-like receptors.
    Tarazi FI; Campbell A; Yeghiayan SK; Baldessarini RJ
    Neuroscience; 1998 Mar; 83(1):169-76. PubMed ID: 9466407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of EEDQ on the synthesis and metabolism of dopamine in preweanling and adult rats.
    Crawford CA; McDougall SA; Bardo MT
    Neuropharmacology; 1994 Dec; 33(12):1559-65. PubMed ID: 7760979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of metyrapone on MK-801-induced alterations in the rat dopamine D1 receptors.
    Czyrak A; Maćkowiak M; Fijał K; Chocyk A; Wedzony K
    Pol J Pharmacol; 1997; 49(5):305-16. PubMed ID: 9566029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Age-related differential recovery rates of rat striatal D-1 dopamine receptors following irreversible inactivation.
    Battaglia G; Norman AB; Creese I
    Eur J Pharmacol; 1988 Jan; 145(3):281-90. PubMed ID: 2895004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of stereotyped behaviour requires stimulation of nigral D1 dopamine receptors.
    Lee CY; Double KL; Crocker AD
    Brain Res; 1995 May; 681(1-2):205-8. PubMed ID: 7552282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential modulation of dopamine D1-receptor binding and mRNA expression in the basal ganglia by the D1-receptor antagonist, SCH-23390.
    Yu J; Coirini H; Källström L; Wiesel FA; Johnson AE
    Synapse; 1998 Sep; 30(1):38-48. PubMed ID: 9704879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regional brain changes in [3H]SCH 23390 binding to dopamine D1, receptors after long-term haloperidol treatment: lack of correspondence with the development of vacuous chewing movements.
    Sasaki T; Kennedy JL; Nobrega JN
    Behav Brain Res; 1998 Feb; 90(2):125-32. PubMed ID: 9521545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The kinetics of [3H]SCH 23390 dissociation from rat striatal dopamine D1 receptors: effect of dopamine.
    Farrell CB; O'Boyle KM
    Eur J Pharmacol; 1994 Jun; 268(1):79-88. PubMed ID: 7925614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoradiographic localization of D1 dopamine receptors in the rat brain with [3H]SCH 23390.
    Savasta M; Dubois A; Scatton B
    Brain Res; 1986 Jun; 375(2):291-301. PubMed ID: 2942221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.
    Makman MH; Dvorkin B
    Brain Res; 1986 Dec; 387(3):261-70. PubMed ID: 2950967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of the selectivities of SCH 23390 with BW737C89 for D1, D2 and 5-HT2 binding sites both in vitro and in vivo.
    Riddall DR
    Eur J Pharmacol; 1992 Jan; 210(3):279-84. PubMed ID: 1351844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Substantia nigra pars reticulata is a highly potent site of action for the behavioral effects of the D1 antagonist SCH 23390 in the rat.
    Trevitt JT; Carlson BB; Nowend K; Salamone JD
    Psychopharmacology (Berl); 2001 Jun; 156(1):32-41. PubMed ID: 11465631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.